Kruuse has launched two products for the treatment of digital dermatitis in cattle: the Bovivet hoof bandage and Kruuse Hoof Gel.
According to the company, an estimated that 70% of dairy herds suffer with digital dermatitis (DD), and it is a growing problem. If not treated, it can persist for months, causing pain and lameness to infected cows. As well as worrying animal welfare concerns, numerous studies have shown that the disease can have a direct impact on milk production and reproduction with financial implications for the dairy farmer.
Traditionally, treatment has involved thoroughly washing the infected hoof, applying an antibiotic/drying agent such as salicylic acid powder and then applying a dressing that must typically remain in place for three days. This method comes with its own problems, including the difficulty dosing salicyclic acid powder correctly, the risk to the user's health when mixing, and the difficulty ensuring that the dressing is correctly applied at the right pressure and that it stays in place.
To help overcome these problems, Kruuse has introduced two products. The first is the ready-to-apply Bovivet complete Hoof Bandage. It is made from a water-repelling material that keeps out unwanted liquids. Its shape and elasticity are designed to keep the bandage in place. Inside the bandage is a treatment pad that makes for easy dosing. The outer stocking design allows for checking on the progress of treatment and for re-application if necessary. The bandage is available in two sizes, large which fits most cattle breeds, and small for calves and small breeds.
The second product, to be used in conjunction with the Bovivet Hoof Bandage, is Kruuse Hoof Gel 38%, containing 38% salicyclic acid. Kruuse says that dosing with this gel product is easier and more accurate than with the powder, making it more economical per treatment. It also reduces potential health risks to the user from inhalation of the powder when mixing.
Kruuse has produced the following instructional video to demonstrate the new products' ease of use and versatility:
Ceva Animal Health has launched two iPhone Apps for veterinary professionals and cat owners.
The 'Metoclopramide' iPhone App calculates both the daily fluid requirements and the volume of metoclopramide to add to the fluid bag for a dehydrated, vomiting cat or dog.
The 'Cat Stress' App helps pet owners to measure the stress levels of cats by asking questions about their home environment; this will help evaluate the effect that modern living has on feline stress levels which may, in turn, encourage owners to take action to help prevent cats developing stress related behavioural or medical problems in later life.
The 'Metoclopramide' iPhone App is available to download from the iTunes store here.
The 'Cat Stress' iPhone Apps is available to download from the iTunes store by searching for 'Cat Stress'.
For further information, please contact your Ceva Animal Health representative or call the veterinary support team on 01494 781510.
For the first time ever, an educational advertisement about the importance of worming cats and the availablity of spot-on treatment, is to be broadcast on TV.
The advert has been produced by Bayer Animal Health, makers of Profender Spot-on, with the aim of driving pet owners to their vet to ask about spot-on worming for their cats.
Bayer product manager Dan White said: "Profender Spot-on solution is a POM-V product. So we have produced a public information style advert which is educational rather than commercial, in accordance with industry regulations on advertising this animal medicine category to the public. It informs and reminds cat owners of the importance of worming, and encourages them to ask their vet for more information.
"In addition, the advert also features details about a competition to find the cat with the biggest personality to celebrate responsible cat ownership, and invites them to upload images and/or videos of their cat onto the website http://www.spotonwormer4cats.com/."
The 20 second advertisement will be broadcast throughout May on ITV1, ITV2, Channels 4 and 5, and Sky One, and is estimated to reach 7 million cat owners.
Practices can obtain a range of campaign support materials by contacting their Bayer Territory Manager or by calling the Bayer Leaflet Line on 0845 2574798 and quoting 'spot-on'.
The RCVS is seeking feedback on a new draft Code of Professional Conduct.
The new Code, which would replace the existing RCVS Guide to Professional Conduct for Veterinary Surgeons, has been produced by a Working Party set up by the RCVS Advisory Committee to review the Guides for both veterinary surgeons and veterinary nurses.
According to the College, the purpose of the review, which last took place over a decade ago, is to ensure guidance to the profession and the public is clear. For example, using consistent language to distinguish between what must be done and what is advised.
The RCVS says the new Code is a short, principles-based document using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance. It also includes:
Clare Tapsfield-Wright, Chairman of the Guides Review Working Party said: "Over the decade or so since it was last reviewed, not only has the Guide become unwieldy in places, but the way that regulators in general publish professional conduct rules has changed. Our draft new Code aims to clarify matters and bring us into line with best practice elsewhere.
"Animal owners are increasingly keen to understand the basis of what the veterinary profession considers to be good professional conduct. The new simplified Code should assist with this understanding."
The new Code, together with the consultation paper, can be downloaded at http://www.rcvs.org.uk/codeconsultation
Comments, which are welcomed from the profession and the public, should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 24 June 2011.
A separate document is under development for veterinary nurses, which will share broadly similar underlying principles and will be the subject of its own consultation.
Dechra Veterinary Products has picked up a major award at the 2011 Veterinary Marketing Awards for a calendar called 'The Horse in History'.
The calendar, designed to promote all of Dechra's equine products but particularly Equipalazone, also won the award for most innovative use of direct mail. The company's website, http://www.dechra.co.uk/, was highly commended in the New Media category.
The John O'Hara Award is made to the VMA category finalist which, in the opinion of the judges, best demonstrates a high level of innovation or adventurousness in an aspect of the advertising mix. Designed to celebrate the unique position of the horse down the ages in culture, art, science and legend, the calendar featured twelve iconic illustrations, from the white horse carved into the chalk hillside in Uffington, Oxfordshire, to Da Vinci's sculpture.
It also included an embedded competition giving practices the opportunity to win practical aids, including wind up torches and water bottles, with the major prize being a trip to Vienna to see the Lipizzaner Stallions at the Spanish Riding School.
Larry King, Senior Brand Manager at Dechra, said: "Horses have had a unique relationship with man for thousands of years and this is what we wanted to celebrate with our calendar. The monthly competition with 100 prizes on offer and the special prize draw at the end of the year gave it a real point of difference and it proved very popular with our customers. It was the first time we'd run such a campaign over twelve months and we believe it to be unique in the animal health sector.
"We were delighted and honoured to win both the award for best use of direct mail and the John O'Hara award for The Horse in History. It will inspire us on our quest to continually set new standards in the way we communicate with our customers."
The Norman Cavalry
Galloping Horse
The Uffington White Horse
The Anatomy of The Horse
Incitatus
Bucephalus
Altamira Cave Painting
Gran Cavallo
Rocinante
American Carousel Horse
Aethenoth
Hill's Pet Nutrition is running an interesting prize draw to highlight a recent study which shows that by using Hill's Prescription Diet Feline c/d Multicare, sterile struvite uroliths can be dissolved in as little as 14 days.1
Send a canine or feline urolith for analysis at the Minnesota Urolith Center by the end of June, and you'll be entered into the draw to win a sparkling diamond worth £2000 (or €2000 in the Republic of Ireland. And no, Hill's hasn't explained why it's a cheaper rock up for grabs in Ireland).
You can download a form at www.hillspet.co.uk/urolith or www.hillspet.ie/urolith to send along with the uroliths.
Almost 80 percent of veterinarians polled on-line recently, used dietary means, either all or some of the time to treat FLUTD.2 It has been suggested that stones account for just 10 percent of non-obstructive and 15 percent of cases of obstructive FLUTD.3
Hill's says that along with its ability to dissolve sterile struvite stones in as little as 14 days, Hill's Prescription Diet Feline c/d Multicare dry pet food also has high levels of omega-3 fatty acids that help to break the cycle of inflammation and reduce discomfort in cats with FIC, making it an appropriate choice in most cases of FLUTD.
References
Elanco Companion Animal Health has launched a novel prescription flea treatment for dogs which, according to the company, combines a rapid kill rate with convenient monthly oral administration.
Elanco says Comfortis Chewable Tablets for Dogs start to kill fleas within 30 minutes, providing 100 per cent control in four hours, the fastest specific claim of any approved flea preventive.
The product is based on a unique active ingredient, Spinosad, a naturally occurring fermentation product of soil bacteria with a unique insecticidal effect. Since its launch in the United States in 2007, Comfortis has established itself as the number one recommended prescription flea medication in that country and has now received European authorisation.
Elanco says the combination of its rapid action and oral method of administration is expected to prove particularly helpful in cases including:
Jannes Nijland, marketing and innovation director for Elanco Companion Animal Health in Western Europe, said: "The veterinary profession has indicated a strong desire for a prescription only flea treatment. While vets remain the 'first port of call' for advice on flea medication, our research shows that only 42 per cent of dog owners still buy their treatments from practices. We believe that the launch of an alternative approach to flea control available from practices could help vets strengthen their client relationships."
He added: "Comfortis is the first product developed and launched by Elanco Companion Animal Health in Western Europe. It is a perfect demonstration of how we intend to deliver on our mission to help veterinarians help pets live longer, healthier and higher quality lives."
For further information about Comfortis, veterinary practices should contact their Elanco key account manager, or to contact the company directly on 01256 779881
Additional information about Elanco is available at www.elanco.com and the company can be contacted via email at elancoCAH.uk@lilly.com
Merck and sanofi-aventis, owners of Merial and Intervet Schering-Plough respectively, have announced that they will not be combining the two animal health businesses as had been planned since March 2010.
In a joint announcement today, the companies said they are discontinuing their agreement primarily because of the increasing complexity of implementing the proposed transaction, both in terms of the nature and extent of the anticipated divestitures and the length of time necessary for the worldwide regulatory review process. The companies agreed that ending their plan is in the best interests of both companies and their respective shareholders, as well as the employees of Merial and Intervet/Schering Plough.
Sanofi-aventis says it remains strongly committed to its animal health activities, which it will continue to develop under the Merial brand as a growth platform of its diversified health business. Merial is one of the world's leading innovation-driven animal healthcare companies dedicated to research, development, manufacturing and commercialization of veterinary pharmaceuticals and vaccines, that generated annual sales of US $ 2.6 billion in 2010.
Merck has also stated its commitment to animal health and Intervet/Schering-Plough, a global leader in the research, development, manufacturing and sale of veterinary medicines which generated sales of US $ 2.9 billion in 2010
As a result of termination, both Merial and Intervet/Schering-Plough will continue to operate independently.
Ceva Animal Health has launched Cardio Academy. The company says it's the first international cardiology e-learning programme offering CPD from leading international specialists.
The programme can be accessed at www.cardioacademy.cevalearn.com. It consists of a series of impressively well-produced interactive multimedia presentations lasting around 30 minutes, at the end of which you can download a CPD certificate.
The first two sessions, which are now available online, cover the Pathophysiology of Mitral Valve Disease, by Adrian Boswood, and Clinical Examination of the Cardiac Dog, by Gérard Le Bobinnec.
Product manager, Fraser Broadfoot MRCVS, said: "There have been many advances in the diagnosis and treatment of heart failure in recent years. The aim of this website is to become a practical and up-to-date resource on the management of heart failure in practice."
Vets Now, in cooperation with its host practices and the Veterinary Poisons Information Service, is launching a new 'Tox Box' service giving veterinary surgeons 24 hour direct access to the treatments that they are most likely to need, and least likely to stock, in a poisoning emergency.
Vets Now says this new service represents a significant step forward in the ease and availability of care for the intoxicated patient.
Through Tox Box, any vet calling the VPIS advice line after 31st March 2011 will be able to access the drugs required in a poisoning emergency at selected Vets Now clinics and their host practices across the UK. Drugs will be available at cost, plus a small handling charge.
Amanda Boag, Clinical Director at Vets Now said: "We are delighted to be working in partnership with VPIS to offer vets this life-saving service for pets across the UK.
"As emergency and critical care practitioners we frequently deal with poisoning cases and are pleased to be able to use our clinics to allow vets access to the treatments they need in a hurry.
"Tox Box is a service which has been designed to help enhance the current VPIS advice service whereby vets can now easily gain access to those drugs they are most likely to need to treat toxicities, but not stock internally, such as plasma and Adder anti-venom. The service VPIS provides is very important for vets, and we hope that this additional provision will greatly benefit them and the pets they are caring for."
Alex Campbell, Head of Services at VPIS said: "We are looking forward to working in partnership with Vets Now to improve outcomes for poisoned animals and their owners.
"Poisons can have deadly affects on animals if not treated quickly. Previously vets may have had to call round several hospitals or practices to source the recommended drug whilst their patient's health deteriorates. Through Tox Box we can help them access the drug without delay and provide case-specific guidance to ensure the animal receives optimum care."
The VPIS 24/7 telephone number to ring is: 020 7188 0200
See attached document for details of BMUS meeting in Brighton which has a veterinary stream
Following last month's news that Hill's had pulled out of BSAVA and would instead be found at a pizza restaurant round the corner from the NIA, comes a fresh announcement that the company has changed venues, and will now be at the Slug and Lettuce for the duration of Congress.
What next? I'm half expecting another press release before Congress kicks off, inviting us all to meet at John's.
Voting in this year's RCVS and VN Councils elections has now opened, with veterinary surgeons and veterinary nurses able to cast their votes online, by post or by text message.
All candidate details and ballot papers have been posted earlier this week so should be landing on doormats imminently.
As in previous years, there is an opportunity for voters to quiz the candidates on VetSurgeon.org and VetNurse.co.uk. Questions submitted before 24th March will be entered into a draw to win one of three 6-bottle mixed cases of wine. Thereafter, there will be an open forum on both sites.
As in previous years, the College will make an optional 20p charitable donation to the Veterinary Benevolent Fund on behalf of each person who votes.
Lydia Brown, President of the VBF, said: "The Veterinary Benevolent Fund is very grateful for funds raised through the elections. We appreciate that life in practice can be stressful, and offer support in a variety of ways to veterinary surgeons and veterinary nurses."
RCVS Council comprises 40 members: four are appointed by the Privy Council, 12 by the veterinary schools and 24 by direct election.
Each member is appointed for a four-year term of office. Every year, six members of Council retire at the Annual General Meeting, though may seek re-election.
In 2011, ten candidates are standing for the six seats available, including six incumbent Council members. The candidates are:
RCVS VN Council comprises 17 members: eight elected veterinary nurses, six veterinary surgeon members (including three from RCVS Council), one Lantra representative and two lay members.
Two seats are usually available each year, with each member serving a four-year term.
This year an extra seat for a one-year term is available, due to a member retiring mid-term; this will be filled by the third-placed candidate.
There are four candidates for the three seats:
All votes must be received before 5pm on 27 April 2011 - a slightly earlier deadline than usual, which takes account of the extra public holiday for the Royal Wedding.
Any veterinary surgeon who has not received their ballot paper should contact Ian Holloway (020 7202 0727 i.holloway@rcvs.org.uk) for an official duplicate; veterinary nurses missing their ballot papers should contact Annette Amato (020 7202 0713 a.amato@rcvs.org.uk).
BCF, the veterinary imaging company, has launched a competition in which you can test your knowledge on a series of x-ray and ultrasound images for the chance to win a Sony Cyber Shot digital camera.
Visit the BCF website to enter - www.bcftechnology.com/
Entries to be in by 31st May 2011 and the winner will be drawn at random on the 6th of June 2011.
Ceva Animal Health has introduced Cevazuril, a toltrazuril-based oral solution for the control of diarrhoea in sucking pigs. Cevazuril is a one-dose treatment that comes in two pack sizes, both with dosing pumps, for convenient administration to large or small herds.
Ceva says newborn sucking piglets are especially sensitive to coccidiosis and infection may result in lost daily gain of almost 2kg in the first 28 days, due to diarrhoea. The control of coccidiosis using toltrazuril prevents damage to the intestinal mucosa caused by the developmental stages of Isospora suis, helping to preserve digestive function and maintain optimal growth rate.
Toltrazuril is absorbed very slowly in the intestine for longer-lasting action. It works on all intracellular developmental stages of coccidia and reduces oocyst production, even if administered after the appearance of the first oocysts in the faeces of the host.
According to the company, extensive trials showed that three day old piglets treated with toltazuril at 20mg/kg gained 801 grams at weaning and 1601 grams by the end of the post-weaning period compared to control pigs.
Cevazuril is available in a 250ml pack with a pump or a one litre pack with a multi-dose injector. It complements Ceva's swine portfolio which includes the antimicrobials Cevaxel, Coliscour, Florkem, Marbox, Spectam Scourhalt and Tiamvet.
For further product information contact Ceva Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com
CPD Solutions has launched the Webinar Club offering twelve interactive online lectures in key small animal topics each year.
According to the company, the Webinar Club will deliver concise, informative presentations in essential areas for first opinion practice, from specialist tutors in small animal medicine, surgery and imaging. Webinar attendees will have the chance to ask questions in the general discussion at the end of each session.
CPD Certificates will be provided by CPD Solutions for all webinar attendees, and recorded webinars will be available on the Webinar Club website at http://www.veterinarywebinars.com/ for members to watch at any time.
The first webinar on March 22nd is 'How to Manage Diaphragmatic Hernias' by leading soft tissue surgeon Jonathan Bray of Massey University. This is followed by 'Headaches and Pains in the Neck' by Neurology Specialist Simon Platt of the University of Georgia, and 'Decision Making in Oncology' by David Argyle of Edinburgh University.
You can watch a free demonstration webinar by joining Webinar Club as a Silver member at http://www.veterinarywebinars.com/ .
The Royal College of Veterinary Surgeons has launched its new website, which also marks the first public outing for its new livery.
The College highlights the following key changes:
The RCVS says the new corporate look is designed to be fresh, uncluttered and professional, and the new RCVS logo and strapline - "setting veterinary standards" - should leave visitors in no doubt as to the key purpose of the RCVS as a regulatory body. And whilst the new identity is modern in feel, the use of a shield device aims to maintain the link with the College's long history.
According to the College, the new brand was described by the veterinary surgeons and veterinary nurses who helped to develop it as "simple, clear and clean, with a strong message" and "modern and approachable".
President Peter Jinman said: "The College has been accused of being 'confused and confusing' in the past. With the new identity we have endeavoured to clarify that the College is a forward-thinking regulator - despite being established when Queen Victoria was only recently on the throne, and working to 45-year-old legislation.
"Changing the logo, font and colours we use is only a small part of the process though. Our branding review included several layers of research and we now have a better understanding of how we have been perceived, how we would like to be perceived, and what we need to do to get there. This includes changing how we behave and communicate as an organisation, as well as how we position ourselves to the outside world."
The new look, which includes new logos for RCVS Awards, the RCVS Charitable Trust and the Practice Standards Scheme, will be rolled out across other communications elements as the year unfolds, to avoid the unnecessary wastage of materials branded with the old identity.
Meanwhile, the website is a living medium, and the College says it is keen to hear feedback from users about what they like, and what could be improved, to help inform further developments.
Intervet /Schering-Plough Animal Health has announced plans for a third National Vaccination Month Campaign to take place in May.
The campaign, which is aimed at owners of unvaccinated animals, is being fronted by TV presenter and wildlife expert Chris Packham. Intervet / Schering-Plough says it hopes the initiative will counter falling rates of pet vaccination that have been seen since the credit crunch.
In the lead up to National Vaccination Month, the company will be running a pet health awareness national and regional PR campaign backed up by print and TV advertising.
Pet owners will be able to download a voucher for a discounted vaccination in May from http://www.nvmonline.co.uk/. As well as dogs, cats and rabbits, horses will be included in the scheme for the second time.
During the last National Vaccination Month in June 2009, 1022 surgeries participated nationwide and an additional 40,000 animals were vaccinated as a result - 8,000 up on the first campaign run in 2008. According to Intervet / Schering-Plough, many practices saw more than 100 vouchers being redeemed.
The 2009 campaign came after more than a quarter of vets surveyed by Intervet reported concerns about falling levels of vaccination because of the credit crunch. Following the recession and public fears over the deficit, there are concerns that pet owners will cut back even further.
Angus Robinson from Intervet / Schering-Plough Animal Health said: "Research shows that the main reason why people don't vaccinate their pets is a lack of awareness of disease risk. We are also concerned that given the current pressures on household budgets, more people are deciding to cut back on vaccinating their animals with the real risk that this may have a potential effect on levels of herd immunity in the longer term."
He added: "We listened to practices which took part in NVM 2009 and have invested in improving the website to offer a simpler system for surgeries to download and log vouchers for their clients. The site will also drive pet owners to participating vets more quickly. Social media has taken off in a big way since our first campaign in 2008 and we will also be using Facebook and Twitter this time to reflect that. We are hoping that this will reach younger pet owners as data from our last campaign showed that pet owners in their 20s and early 30s were the age group least likely to vaccinate their animals."
Jane Carter of the Drove Veterinary Hospital in Swindon said: "National Vaccination Month is a golden opportunity to communicate the key preventative healthcare messages to new and existing clients. There was a significant outbreak of parvovirus in our area last summer which got a lot of publicity so we are expecting people will really catch onto the campaign this time."
Intervet / Schering-Plough Animal Health veterinary customers planning to take part in National Vaccination Month 2011 can log onto www.nvmonline.co.uk to complete the registration process.
The introduction of the new Level 3 Diploma in Veterinary Nursing has seen an increase in numbers of both students and training practices, according to statistics released today by the RCVS.
Since January, the RCVS has approved over 30 more Training and Auxiliary Training Practices, bringing to a total of 1,559 the number of practices approved for veterinary nurse (VN) training. Scope for practices to train student VNs is increased through the emphasis on Auxiliary Training Practices (aTPs), an option for practices without the full facilities or caseload needed for student training. Students at aTPs complete their in-practice training at other aTPs or full Training Practices. Of the 31 new practices approved since January for student training, eight are aTPs.
The number of VN students enrolling with the RCVS has also increased, with almost double the number enrolling in January 2011, compared with January 2010. There were a total of 1,168 student enrolments in the 12 months from 1 February 2010, compared with 1,121 enrolments in the same period from 1 February 2009.
Libby Earle, Head of the RCVS Veterinary Nursing Department said: "The Level 3 Diploma has been in place for little more than six months, yet VN student numbers are already up. This bodes well for the supply of qualified, competent registered veterinary nurses demanded by veterinary practices, and for those keen to enter the veterinary nursing profession."
The qualification was introduced when the government abolished the National Vocational Qualification (NVQ) system last summer, forcing a change in the vocational qualifications for VNs. The resulting Level 3 Diploma is designed to better meet the needs of practices, colleges, and students themselves.
The results of the UK's first ever public National Equine Health Survey have quantified non-notifiable healthcare issues affecting horses, ponies, donkeys and mules in the UK.
The survey, which was pioneered by The Blue Cross animal charity and is supported by The British Equine Veterinary Association, was carried out last November following two years of pilot schemes. The intention was to find out more about endemic non-notifiable diseases that have never before been recorded in horses, ponies, donkeys and mules, such as coughs, skin diseases and lameness.
The results were announced at the National Equine Forum by Professor Josh Slater, Professor of Equine Clinical Studies at The Royal Veterinary College, who has been working with The Blue Cross on the survey.
A total of 306 sets of records were submitted from 3120 horses in mainly private ownership, with a balance of representation from competition yards, riding schools, welfare charities and studs. A broad range of syndromes and diseases were assessed including colic, sarcoids, laminitis, wounds, dental issues, eye disease, lameness and weight issues.
The results showed that lameness was the most common problem affecting horses (11% of horses surveyed) but that the foot was not the most common cause of lameness and that laminitis (3%) was less common than the 7-8% total that previous surveys had suggested.
Weight management was the next most common issue for horse owners, with 9% of horses recorded as overweight and 8% as underweight. These figures are lower than previous surveys which may be because they are based on the owner's assessment of their horse's weight which is subjective and may vary according to their perception of 'the right weight'.
Skin disease and wounds (5% and 4% respectively) posed a significant problem and colic (2%) was also a common occurrence, with a 6:1 ratio between medical and surgical cases.
The survey is breaking new ground in Europe as well as the UK. Currently Government agencies in all European countries conduct surveillance for prescribed exotic diseases such as West Nile Virus and African Horse Sickness but currently there are no large scale surveillance programmes for endemic diseases.
Professor Slater said: "The regular collection of such data holds numerous benefits to the UK equine industry. Not only does the survey provide a benchmarking facility for equine disease, welfare, standards of care and codes of practice but it will also underpin standards for yard inspection schemes. Not least it confirms the workability of an important template to monitor the serious threat of infectious and exotic disease in the future."
He added: "It's exciting to see hints in the NEHS 2010 survey that data 'straight from the horse's mouth' might challenge some established ideas. For example; the survey found that lameness was common, as you would expect, but that the foot was not the most common cause of lameness, which you might not have expected. This kind of data has never been collected before and is invaluable to the veterinary profession and wider animal welfare industry, helping to inform our future research, training and education. It will be really exciting to see the results of the larger surveys The Blue Cross are running in 2011."
Kerry Doyle, education officer at The Blue Cross said: "We are thrilled to be involved with this innovative project to enhance the future health of our horses and very grateful to all those who have participated in the survey so far. We now need even more horse owners to sign up for the next round so that we can capture as much useful data as possible."
The National Equine Health Survey is currently funded by The Blue Cross but sponsorship is being sought. It is to be conducted twice-yearly with the next census week planned for 9-15 May 2011. All keepers and owners of horses are urged to participate and details of all horse owners will remain anonymous. It's very quick and easy to complete and should only take around five minutes. To register online visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk.
Intervet/Schering-Plough has announced that the license for Leptavoid-H has been improved allowing concurrent use with Bovilis BVD.
Intervet/Schering Plough says that given both vaccines are typically administered in the busy pre-turnout period, this will ease on-farm workload and should help to ensure that all primary courses or boosters take place sufficiently in advance of the period of risk.
Each vaccine is to be given by separate routes and sites, to animals of 8 months or older. The concurrent use in cattle may result in fewer animal interventions, less stress and better welfare.
The studies, undertaken by Intervet/Schering Plough's R&D division in the UK, focussed on both the safety and efficacy aspects of the concurrent administration of Leptavoid-H with Bovilis BVD. The company says no systemic adverse events occurred, there was no effect on the outcome of pregnancy or milk yields and the efficacy in cattle was not compromised.
Leptavoid-H is licensed to reduce the shedding of Leptospira interrogans serovar hardjo in urine. Leptavoid-H is the only Leptospirosis vaccine licensed to improve herd fertility when Leptospira hardjo is the cause of herd infertility, and the only vaccine proven to protect stock against both strains in the UK.
Ceva Animal health has launched Marbox, a broad-spectrum anti-infective, based on marbofloxacin, for the rapid treatment of bovine mastitis and respiratory disorders. According to the company, Marbox effectively provides two products in one bottle because it can be used as a high dose single injection or administered at a lower dose over several days.
Ceva says mastitis and respiratory disorders currently account for around 60% of antimicrobial prescriptions. Marbox can be used intramuscularly as a single injection for the treatment of respiratory infection. Alternatively it can be used for the treatment of acute mastitis; intravenously for the first injection and then subcutaneously at a lower dose over three days. It has a milk withdrawal of just 36 hours after subcutaneous injection.
Marbox is presented in an ergonomic CLAS vial which makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. It is available in 100 and 250 vial sizes and contains 100mg marbofloxacin per ml.
Marbox can be used in combination with Meloxidyl, Ceva's new, single shot anti-inflammatory. The product joins Ceva's bovine range of anti-infectives, which includes Cevaxel, Florkem and Spectam Injectable.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
Petplan has announced the finalists for the 2011 Petplan Veterinary Awards.
Now in its 12th year, the Petplan Veterinary Awards received its biggest response yet with over 2,800 nominations submitted for exceptional veterinary staff all over the UK.
The finalists for each of the categories are as follows:
Vet of the YearCharles Bagnal, Orwell Veterinary Group - Ipswich Alison Laurie, Crown Vets - Highlands Daniel Parry, Village Vet Garden Suburb - London
Vet Nurse of the YearEmma Clare, Copthorne Veterinary Clinic - Shropshire Maria Corcoran, Orwell Veterinary Group - Ipswich Ingrid Hunt, Cranbrook Veterinary Centre - Devon
Support Staff of the YearBev Millward, Milton Keynes Veterinary Group - Milton KeynesLauren Hunter, The Ferns Veterinary Practice - Dunkeld Patty Fraser, Loch Leven Equine Practice - Kinross
Vet Practice of the YearAshfield House Veterinary Hospital Ltd - Nottinghamshire Emersons Green Veterinary Surgery Ltd - Avon Leonard Brothers Veterinary Centre Ltd - Shropshire
Alison Andrew, Petplan's Marketing Manager, said: "The nominations get bigger and better every year and we're absolutely delighted to announce the finalists for 2011. With 70% of veterinary practices within 3 miles of their patients, veterinary staff are an important part of the community and that's why we feel it important that they have a chance to receive the recognition they deserve. We're looking forward to revealing the winners on 31st of March."
All finalists will be invited to an elegant awards ceremony that will take place on 31st March at the Birmingham Town Hall, where the winners will be announced.
For further information, visit http://www.petplanvet.co.uk/
A new study carried out by academics at the University of Bristol's Animal Welfare and Behaviour research group has revealed that chickens empathise. So, if you've wondered why the chicken crossed the road, it was probably to help a friend.
More specifically, the research - funded by the BBSRC Animal Welfare Initiative and published online in the Proceedings of the Royal Society B. - demonstrated that domestic hens show a clear physiological and behavioural response when their chicks are mildly distressed.
Researchers say the study is the first to demonstrate that birds possess one of the important attributes that underpins empathy, and the first study to use both behavioural and physiological methods to measure these traits in birds.
During one of the controlled procedures, when the chicks were exposed to a puff of air, the hens' heart rate increased and eye temperature decreased. The hens also changed their behaviour, and reacted with increased alertness, decreased preening and increased vocalisations directed to their chicks.
Some of these responses have previously been used as indicators of an emotional response in animals. In domestic chickens, time spent standing alert is associated with higher levels of fear. Previous research carried out by the same group has shown that hens also selectively avoid surroundings associated with high levels of standing and low levels of preening.
Jo Edgar, PhD student in the School of Veterinary Sciences, said: "The extent to which animals are affected by the distress of others is of high relevance to the welfare of farm and laboratory animals.
"Our research has addressed the fundamental question of whether birds have the capacity to show empathic responses.
"We found that adult female birds possess at least one of the essential underpinning attributes of 'empathy'; the ability to be affected by, and share, the emotional state of another."
The researchers say they used chickens as a model species because, under commercial conditions, chickens will regularly encounter other chickens showing signs of pain or distress due to routine husbandry practices or because of the high levels of conditions such as bone fractures or leg disorders.
Reference:'Avian maternal response to chick distress', J L Edgar, J C Lowe, E S Paul, C J Nicol, published online ahead of print Proceedings of the Royal Society B, 9 March 2011.
Picture:Gemma Richards, University of Bristol
Veterinary surgeons are being advised against taking a heavy handed approach to hyperthyroidism by key opinion leaders, including Professor Danielle Gunn-Moore, a Specialist in Feline Medicine at the Royal (Dick) School of Veterinary Studies in Edinburgh.
Professor Gunn-Moore said: "Hyperthyroidism is not a condition that develops suddenly. It is a slowly progressive disease. The cat's body adapts to being hyperthyroid over a relatively long period of time. That is why it is best to return it to a euthyroid state in a controlled manner, rather than trying to crash the thyroxine concentration back down to normal as quickly as possible. Too fast a fall in thyroxine concentration can significantly exacerbate renal compromise and may cause serious harm.
"My recommendation is that you should start with a low dose of anti-thyroid medication and increase it if needed, after assessing the initial response to treatment. Any increase should be made in the smallest increments possible."
Dechra Veterinary Products - makers of Felimazole, the first medical treatment licensed in Europe for feline hyperthyroidism - is inviting vets to stand 700/701 at the BSAVA Congress to find out more about the latest thinking and new research which shows that treatment of hyperthyroid cats can result in iatrogenic hypothyroidism, that hyperthyroid cats are significantly more likely to develop azotaemia than euthyroid cats, and that hypothyroid cats that developed azotaemia have significantly shorter survival times.1
Further information on Felimazole is available by calling 01939 211 200 or visiting http://www.dechra.com/
References:1. Williams, T. et al (2010) JVIM 24: 1086-1092